Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.11779/1129
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPatel, Charmi-
dc.contributor.authorKhouyr, Antoine El-
dc.contributor.authorHuang, Ahong-
dc.contributor.authorWang, Li-
dc.contributor.authorBaşer, Onur-
dc.contributor.authorJoshi, Kruti-
dc.date.accessioned2019-08-23T07:41:49Z
dc.date.available2019-08-23T07:41:49Z
dc.date.issued2019-
dc.identifier.citationPatel, C., El, K. A., Huang, A., Wang, L., Baser, O., & Joshi, K. (August 08, 2019). Health Outcomes Among Patients Diagnosed with Schizophrenia in the US Veterans Health Administration Population Who Transitioned from Once-Monthly to Once-Every-3-Month Paliperidone Palmitate: An Observational Retrospective Analysis. Advances in Therapy. 1-13.en_US
dc.identifier.issn0741-238X-
dc.identifier.issn1865-8652-
dc.identifier.urihttps://hdl.handle.net/20.500.11779/1129-
dc.identifier.urihttps://doi.org/10.1007/s12325-019-01039-9-
dc.description.abstractThere is limited literature on treatment patterns, healthcare resource utilization (HRU), and costs among patients who transition from once-monthly paliperidone palmitate (PP1M) to once-every-3-month paliperidone palmitate (PP3M) in a real-world setting. Hence, this study compared treatment patterns, HRU, and costs 12-month pre- and post-PP3M transition among Veteran’s Health Administration (VHA) patients with schizophrenia.en_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofAdvances in Therapyen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAntipsychotic Agentsen_US
dc.subjectHealthcare Costsen_US
dc.subjectMedication Adherenceen_US
dc.subjectNeurologyen_US
dc.subjectPaliperidone Palmitateen_US
dc.subjectSchizophreniaen_US
dc.titleHealth outcomes among patients diagnosed with schizophrenia in the US veterans health administration population who transitioned from once-monthly to once-every-3-month Paliperidone Palmitate: an observational retrospective analysisen_US
dc.typeArticleen_US
dc.identifier.doi10.1007/s12325-019-01039-9-
dc.identifier.pmid31396809en_US
dc.identifier.scopus2-s2.0-85070287900en_US
dc.description.woscitationindexScience Citation Index Expanded - Social Science Citation Index-
dc.identifier.wosqualityQ2-
dc.description.WoSDocumentTypeArticle
dc.description.WoSInternationalCollaborationUluslararası işbirliği ile yapılan - EVETen_US
dc.description.WoSPublishedMonthEkimen_US
dc.description.WoSIndexDate2019en_US
dc.description.WoSYOKperiodYÖK - 2019-20en_US
dc.identifier.scopusqualityQ1-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.endpage13en_US
dc.identifier.startpage1en_US
dc.departmentİİSBF, Ekonomi Bölümüen_US
dc.identifier.wosWOS:000488950000028en_US
dc.institutionauthorBaşer, Onur-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextopen-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.fulltextWith Fulltext-
item.openairetypeArticle-
Appears in Collections:Ekonomi Bölümü Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Files in This Item:
File Description SizeFormat 
Health-Outcomes-Among-Patients-Diagnosed-with-Schizophrenia-in-the-US-Veterans-Health-Administration-Population-Who-Transitioned-from-OnceMonthly-to-OnceEvery3Month-Paliperidone-Palmitate-An-Observational-R.pdfYayıncı Sürümü - Makale368.57 kBAdobe PDFThumbnail
View/Open
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

4
checked on Aug 1, 2024

WEB OF SCIENCETM
Citations

4
checked on Jun 23, 2024

Page view(s)

4
checked on Jun 26, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.